home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

A new ranking of scientific journals

 
  September, 29 2008 11:43
your information resource in human molecular genetics
 
     
The Impact Factor (IF) of a scientific journal has been a key parameter for many years for the evaluation of the academic output of research groups and scientists and, in many cases, of the relative quality of individual papers.

A recent paper in FASEB Journal describes the analysis of a new ranking of journals, in comparison with the standard IF. The SCImago Journal Ranking (SJR) is based in the Scopus database (covering more than 13.000 journals); it is freely available and incorporates in the calculations a weighting factor accounting for the relative importance of the journals that are generating the respective citations. The authors found that the median absolute change in the ranking positions between IF and SJR was 29-32 for the top 100 journals.

This freely available resource can be a useful alternative tool for the researchers working in human genetics, in terms of the evaluation and consideration of publications in the area and to get an overview of the performance (number of publications, number of citations, number of citations per publication, H index, among others) of regions or countries in specific research subjects and years.

Author: Matthew E. Falagas, Alfa Institute of Biomedical Sciences (AIBS), Marousi, Greece. E-mail: m.falagas@aibs.gr

Reference:

Falagas ME, Kouranos VD, Arencibia-Jorge R, Karageorgopoulos DE. Comparison of SCImago journal rank indicator with journal impact factor. FASEB J. 2008 Aug;22(8):2623-8.

Paper available online.

The SJR server is available at SCImago Journal Ranking website


Message posted by: Diego Forero

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.